MARKET

DSS

DSS

Dss Inc
AMEX
0.2697
-0.0081
-2.92%
After Hours: 0.2842 +0.0145 +5.38% 17:56 09/23 EDT
OPEN
0.2980
PREV CLOSE
0.2778
HIGH
0.2994
LOW
0.2541
VOLUME
427.74K
TURNOVER
0
52 WEEK HIGH
1.330
52 WEEK LOW
0.2541
MARKET CAP
37.49M
P/E (TTM)
-0.6493
1D
5D
1M
3M
1Y
5Y
DSS Receives Non-Compliance Notice From NYSE American
DSS Receives Non-Compliance Notice From NYSE American
MT Newswires · 08/31 06:15
NYSE sends non-compliance notice to DSS over failure related to timely Form 10-Q filing
The NYSE has sent a non-compliance notice to DSS (NYSE:DSS) relating to the sto...
Seekingalpha · 08/30 21:16
BRIEF-DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing
BRIEF-DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing
Reuters · 08/30 20:56
BRIEF-DSS Inc - Impact BioMedical Develops Quantum Antihistamine
BRIEF-DSS Inc - Impact BioMedical Develops Quantum Antihistamine
Reuters · 07/26 13:13
Impact BioMedical Develops Quantum Antihistamine
ROCHESTER, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculat...
GlobeNewswire · 07/26 12:00
DSS stock pops on licensing deal with ProPhase Labs
DSS (NYSE:DSS) shares popped around 17% after the co...
Seekingalpha · 07/22 11:16
BRIEF-DSS Announces Licensing Of Impact Biomedical’s Linebacker Portfolio To Prophase Labs
BRIEF-DSS Announces Licensing Of Impact Biomedical’s Linebacker Portfolio To Prophase Labs
Reuters · 07/21 21:16
DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs
DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs
Benzinga · 07/21 21:01
More
About DSS
DSS, Inc., through its subsidiaries, is engaged in various business, including product packaging, biotechnology, direct marketing, commercial lending, securities and investment management, alternative trading, digital transformation, secure living and alternative energy. The Company operates through five segments: Product Packaging, Biotechnology, Direct Marketing, Commercial Lending, and Securities and Investment Management. Its Product Packaging segment operates through, Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Its Biotechnology segment operates through, Impact BioMedical, Inc., which targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Its Commercial Lending segment operates through, American Pacific Bancorp, which provides an integrated suite of financial services for businesses.

Webull offers kinds of DSS Inc stock information, including AMEX:DSS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DSS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DSS stock methods without spending real money on the virtual paper trading platform.